Dip in Dead Sea may help diabetics: study

Floating in the Dead Sea for just 20 minutes may help diabetics lower blood sugar levels, according to a study by Israeli researchers highlighted in Haaretz on Tuesday.

The research was carried out by scientists from Ben Gurion University and Soroka Medical Centre in Beersheva, both in Israel's Negev desert, the paper said.

In the experiment, 14 people with , aged 18 to 65, showed a significant drop in after sitting for 20 minutes in a pool of Dead .

Glucose levels dropped on average from 163 to 151 milligrams per decilitre (mg/dl) -- 13.5 percent -- immediately afterwards, according to the report.

Blood sugar dropped even further to 141.3 mg/dl after an hour's dip in the water.

The bathing experience did not appear to have any negative effect on other blood values such as levels of insulin, hormones or c-peptide, the researchers said.

A control group of six healthy individuals did not register any changes in .

Professor Shaul Sukenik, who led the research at Ben Gurion, described the results as "promising."

"In the event that the findings are confirmed in further studies, a drop in blood glucose levels will allow diabetics who bathe in the Dead Sea to use less medication," he told the newspaper.

"We cannot determine this on the basis of the current study, but the findings do suggest this," he said.

The research team is now trying to raise funds to broaden the research to examine the effect of a daily dip in the Dead Sea across a three-week period, the paper said.

The findings will be published in this month's edition of the Israel Medical Associations journal, HaRefua.

(c) 2011 AFP

Citation: Dip in Dead Sea may help diabetics: study (2011, August 30) retrieved 8 May 2024 from https://medicalxpress.com/news/2011-08-dip-dead-sea-diabetics.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Study suggests drug significantly improves glycemic control in type one diabetics on insulin

 shares

Feedback to editors